Eli Lilly and Company (LILY34) — Cash Flow Quality Index
Eli Lilly and Company (LILY34) has a Cash Flow Quality Index of 0.49x as of December 2025. Operating cash flow of R$3.22 Billion is below net income of R$6.64 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Eli Lilly and Company (LILY34) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eli Lilly and Company Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Eli Lilly and Company across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LILY34 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Eli Lilly and Company (2014–2025)
Year-by-year earnings quality comparison for Eli Lilly and Company. For live market cap and the full company financial profile, see how much is Eli Lilly and Company worth.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | R$16.81 Billion | R$20.64 Billion | ▼ -2.2% |
| 2024 | 0.83x | R$8.82 Billion | R$10.59 Billion | ▼ -23.6% |
| 2023 | 1.09x | R$5.71 Billion | R$5.24 Billion | ▼ -3.9% |
| 2022 | 1.13x | R$7.08 Billion | R$6.24 Billion | ▼ -12.8% |
| 2021 | 1.30x | R$7.26 Billion | R$5.58 Billion | ▲ +24.0% |
| 2020 | 1.05x | R$6.50 Billion | R$6.19 Billion | ▲ +80.5% |
| 2019 | 0.58x | R$4.84 Billion | R$8.32 Billion | ▼ -66.0% |
| 2018 | 1.71x | R$5.52 Billion | R$3.23 Billion | ▼ -3.5% |
| 2016 | 1.77x | R$4.85 Billion | R$2.74 Billion | ▲ +44.0% |
| 2015 | 1.23x | R$2.96 Billion | R$2.41 Billion | ▼ -34.0% |
| 2014 | 1.87x | R$4.46 Billion | R$2.39 Billion | — |